Page last updated: 2024-08-24

3-carbethoxypsoralen and Actinic Reticuloid Syndrome

3-carbethoxypsoralen has been researched along with Actinic Reticuloid Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hönigsmann, H; Wolff, K1
Kimura, S; Mizuno, N; Takakuwa, Y; Takashima, A; Yamamoto, K1
Hirano, S; Kimura, S; Mizuno, N; Yoshikawa, K1

Other Studies

3 other study(ies) available for 3-carbethoxypsoralen and Actinic Reticuloid Syndrome

ArticleYear
Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    National Cancer Institute monograph, 1984, Volume: 66

    Topics: 5-Methoxypsoralen; DNA; Furocoumarins; Humans; Methoxsalen; Photochemotherapy; Photosensitivity Disorders; Psoriasis; PUVA Therapy

1984
Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    The British journal of dermatology, 1991, Volume: 124, Issue:1

    Topics: Adult; Dermatitis, Contact; Female; Furocoumarins; Humans; Incidence; Male; Methoxsalen; Middle Aged; Photosensitivity Disorders; Psoriasis; PUVA Therapy; Skin Tests

1991
Topical application of 3-carbethoxypsoralen plus UVA in the treatment of psoriasis.
    The Journal of dermatology, 1985, Volume: 12, Issue:3

    Topics: Adult; Aged; Female; Furocoumarins; Humans; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Psoriasis; PUVA Therapy; Serum Albumin

1985